Factorial effect of process parameters on pharmaceutical characteristics of biodegradable PLGA microparticles

International Journal of Drug Delivery

Volumn 1, Issue 2, 2011, Pages 324-334

  Derakhshandeh, K ^a,b   Nikmohammadi, M ^a   Hosseinalizadeh, A ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran University of Medical Science   (Iran)

Author keywords

Full factorial design; Furosemide; PLGA microparticles

Indexed keywords

EMULSIFYING AGENT; FUROSEMIDE; PHOSPHATE; POLYGLACTIN; SOLVENT; MICROSPHERE; PHOSPHATE BUFFERED SALINE;

ARTICLE; BIODEGRADABILITY; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EVAPORATION; FACTORIAL DESIGN; INTESTINE FLUID; MATHEMATICAL MODEL; MICROENCAPSULATION; PHARMACOLOGICAL PARAMETERS; SIMULATION; STOMACH ACID; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; INTESTINE ABSORPTION; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PROCESS OPTIMIZATION; PRODUCT RECOVERY; STOMACH PH; SUSTAINED DRUG RELEASE;

EID: 79958159900     PISSN: None     EISSN: 09750215     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aceves JM, Cruz R, Hernandez E. Preparation and characterization of Furosemide-Eudragit controlled release systems. Int J Pharm. 2000;195:45-53.
2. Beyers H, Malan S, Van der watt JG, De villiers MM. Structure-solubility relationship and thermal decomposition of furosemide. Drug Dev Ind Pharm. 2000;26(10):1077-1083.
3. Hua A, Jones SA, Villiers MMD, Lvov YM. Nano-encapsulation of furosemide microcrystals for controlled drug release. J Control Rel. 2003;86:59-68.
4. Flanagan ShD, Benet LZ. Net secretion of furosemide is subject to indomethacin inhibition, as observed in caco-2 monolayer and excised rat jejunum. J Pharm Res. 1999;16:221-224.
5. Bundgaard H, Noorgaard T, Nielsen NM. Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int J Pharm. 1988;42:217-224.
6. Haznedar S, Dortunc B. Preparation and in vitro evaluation of Eudragit microparticles containing acetazolamide. Int J Pharm. 2004;269:131-140.
7. Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int. J. Pharm. 2008;363(1-2):26-39.
8. Dawes GJS, Fratila-Apachitei LE, Mulia K, Apachitei I, Witkamp G, Duszczyk J. Size effect of PLGA spheres on drug loading efficiency and release profiles. J Mater Sci: Mater Med. 2008. DOI: 10.1007/s10856-008-3666-0.
9. Zhang X, Wiss U, Pichora D, Goosen MFA. A mechanistic study of antibiotic release from biodegradable poly (D, L-lactide) cylinders. J. Control. Rel. 1994;31:129-144.
10. O'Hara P, Hickey AJ. Respirable PLGA microparticles containing rifampicin for the treatment of tuberculosis: Manufacture and characterization. J. Pharm. Res. 2000;17(8):955-961.
11. Kompella UB, Koushik K. Preparation of drug delivery systems using supercritical fluid technology. Crit. Rev. Ther Drug Carrier Syst. 2001;18(2):173-199.
12. Vandervoort J, Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int J Pharm. 2002;238(1-2):77-92.
13. O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Delivery Rev. 1997;28:25-42.
14. Derakhshandeh K, Erfan M, Dadashzadeh S. Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics. Eur J pharm Biopharm. 2007;66:34-41.
15. Gohel M, Amin A. Formulation optimization of controlled release diclofenac sodium microparticles using factorial design. J Control Rel. 1998;51(2-3):115-122.
16. Mayank D, Sandip B, Mansoor M. Formulation optimization for the nanoparticles-in-microsphere hybrid oral delivery system using factorial design. J Control Rel. 2006;110:422-430.
17. Mathew ST, Devi SG, KV S. Formulation and Evaluation of Ketorolac Tromethamine-loaded Albumin Microspheres for Potential Intramuscular Administration. AAPS Pharm Sci Tech. 2007;8(1):Article 14.
18. Rawat M, Saraf Sh, Saraf S. Influence of Selected Formulation Variables on the Preparation of Enzyme-entrapped Eudragit S100 Microspheres. AAPS Pharm Sci Tech. 2007;8(4):Article 116.
19. Patel JK, Patel RP, Amin AF, Patel MM. Formulation and Evaluation of Mucoadhesive Glipizide Microspheres. AAPS Pharm Sci Tech. 2005;6(1):49-55.
20. Dillen K, Vandervoort J, Mooter GVD, Verheyden L, Ludwig A. Factorial design, physicochemical characterization and activity of ciprofloxacin-PLGA nanoparticles. Int J Pharma. 2004;275:171-187.
21. Bozkir A, Saka OM. Formulation and investigation of 5-FU nanoparticles with factorial design-based studies. J Farmaco. 2005;60:840-846.
22. Singh D, Saraf Sh, Dixit VK, Saraf S. Formulation Optimization of Gentamicin Loaded Eudragit RS100 Microparticles Using Factorial Design Study. Biol Pharm Bull. 2008;31(4):662-667.
23. Krznar DB, Filipovic J, Zorc B, Zoyko M. Dissolution of celecoxib from mucoadhesive disks based on polyaspartamide derivatives. Acta. Pharm. 2006;56:463-471.
24. Sancho CM, Herrero-Vanrell R, Negro S. Vitamin A palmitate and acyclovir biodegradable microspheres for intraocular sustained release. Int J Pharma. 2006;326:100-106.
25. Tanwar YS, Naruka PS, Ojha GR. Development and evaluation of floating microspheres of verapamil hydrochloride. J Rev Bras Cienc Farm. 2007;43:529-534.
26. Emami J. In vitro-In vivo Correlation: from theory to applications. J Pharm Pharmaceut Sci. 2006;9:169-189.
27. Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, Shah VP, Lesko LG, Chen ML, Lee VHL, Hussain AS. Biopharmaceutics Classification System: The scientific basis for biowaiver extensions. J Pharm Res. 2002;19:921-925.
28. Martinez M, Augsburger L, Johnston T, Jones WW. Applying the Biopharmaceutics Classification System to veterinary pharmaceutical products: Part I: Biopharmaceutics and formulation considerations. J. Advanced Drug Delivery Reviews. 2002;54(6):805-824.
29. Sharma P, Chawla HPS, Panchagnula R. Analytical method for monitoring concentrations of cyclosporin and lovastatin in vitro in an everted rat intestinal sac absorption model. J Chromatography B. 2002;768:349-359.
30. Nessler J, Skrzypek A. Chronic heart failure in the elderly: a current medical problem. Pol. Arch. Med. Wewn. 2008;118(10):572-580.
31. Davis SS. The design and evaluation of controlled release systems for gastrointestinal tract. J Control Rel. 1985;2:27-38.